PTEN and neoplasm: Moreover, combination treatment of olaparib and ONC206 for 4 weeks synergistically inhibited tumor growth in our Lkb1fl/flp53fl/fl transgenic mouse model of endometrioid EC without obvious toxicity, implying that this combination treatment may have inhibitory effects in EC patients with wild type PTEN or PTEN loss tumors.